Literature DB >> 17521520

Mania in the medically ill.

Monica Arora1, Joan Daughton.   

Abstract

Manic symptoms frequently occur in patients with comorbid medical disorders and present a diagnostic and treatment challenge. Manic symptoms may be due to an independent psychiatric illness, may be induced or precipitated by a medical condition, or may result from medication or substance use. The presence of manic symptoms in medically ill patients can lead to misdiagnosis or complicate the management of comorbid medical illness. It is of paramount importance to identify the etiology of the mania and, in particular, differentiate primary from secondary mania. Management of mania in the medically ill should focus on treating the underlying medical condition, medication management (antipsychotic agents, mood stabilizers, and/or benzodiazepines), and psychotherapy (if needed). Selecting appropriate medication for treatment requires basic knowledge of the pharmacokinetics of the medications, their side effect profile, and drug-drug interaction. The majority of deficits accompanying secondary mania resolve with treatment of the underlying cause, and supportive psychopharmacology may be all that is needed, but if symptoms persist, patients may need medications for a longer duration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521520     DOI: 10.1007/s11920-007-0024-8

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  21 in total

Review 1.  Neurobehavioral aspects of movement disorders.

Authors:  G Glosser
Journal:  Neurol Clin       Date:  2001-08       Impact factor: 3.806

2.  Secondary mania in older adults.

Authors:  John O Brooks; Jennifer C Hoblyn
Journal:  Am J Psychiatry       Date:  2005-11       Impact factor: 18.112

3.  General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era.

Authors:  A M Kilbourne; A C Justice; L Rabeneck; M Rodriguez-Barradas; S Weissman
Journal:  J Clin Epidemiol       Date:  2001-12       Impact factor: 6.437

4.  Primary mania versus HIV-related secondary mania in Uganda.

Authors:  Etheldreda Nakimuli-Mpungu; Seggane Musisi; Steven Kiwuwa Mpungu; Elly Katabira
Journal:  Am J Psychiatry       Date:  2006-08       Impact factor: 18.112

5.  The clinical use of lithium carbonate in old age: a review.

Authors:  K I Shulman; S Mackenzie; B Hardy
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1987       Impact factor: 5.067

Review 6.  Mood disorders in multiple sclerosis: diagnosis and treatment.

Authors:  S L Minden
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

7.  Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.

Authors:  D G Daniel; S G Potkin; K R Reeves; R H Swift; E P Harrigan
Journal:  Psychopharmacology (Berl)       Date:  2001-05       Impact factor: 4.530

Review 8.  Mania in neurologic disorders.

Authors:  M F Mendez
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

Review 9.  Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.

Authors:  Fady Rachid; Gilles Bertschy; Guido Bondolfi; Jean-Michel Aubry
Journal:  J Clin Psychiatry       Date:  2004-11       Impact factor: 4.384

Review 10.  Secondary mania: diagnosis and treatment.

Authors:  D L Evans; M J Byerly; R A Greer
Journal:  J Clin Psychiatry       Date:  1995       Impact factor: 4.384

View more
  1 in total

Review 1.  Predictive animal models of mania: hits, misses and future directions.

Authors:  Jared W Young; Brook L Henry; Mark A Geyer
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.